FDA Inspection 854859 — New York Blood Center, Inc.

New York Blood Center, Inc. — FEI 3010484696

The FDA completed an inspection of New York Blood Center, Inc. on November 12, 2013 in Paramus, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 12, 2013
Fiscal Year
2014
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Paramus, NJ (United States)